hrt and tirzepatide New research from a Mayo Clinic–led study suggests that postmenopausal women using menopause hormone therapy may experience greater weight loss when treated with tirzepatide, a GLP-1–based medication for overweight obesity. In Hormone Therapy Supercharges Tirzepatide: A

For most peptides excluded from oral delivery by the negative-selection framework, long-acting injectable formulations represent the most practical, pharmacokinetically superior, and economically sustainable alternative

However, you should still inform your GP as both medications can cause overlapping side effects that require monitoring

Individuals with specific alleles in GLP1R may show more robust appetite suppression to semaglutide alone, while those with high-sensitivity GIPR variants may benefit disproportionately from tirzepatide's dual mechanism

At Regain Functional Medicine + Aesthetics, we understand your frustration, and were here to help